Therapeutic Advancements in the Endovascular Management of Acute Ischemic Stroke
Stroke is the major cause of disability and the second leading cause of death worldwide. Acute ischemic stroke is responsible for ∼85% of all strokes, with 24% to 46% attributable to large‐vessel occlusion, which are typically associated with worse outcomes. Although the initial efforts to develop e...
Main Authors: | Mahmoud H. Mohammaden, Diogo C. Haussen, Raul G. Nogueira |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-11-01
|
Series: | Stroke: Vascular and Interventional Neurology |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/SVIN.121.000168 |
Similar Items
-
Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke
by: Vicky Chalos, et al.
Published: (2019-06-01) -
Trevo 2000: Results of a Large Real‐World Registry for Stent Retriever for Acute Ischemic Stroke
by: Mandy J. Binning, et al.
Published: (2018-12-01) -
Endovascular Therapy for Acute Ischemic Stroke in Patients With Prestroke Disability
by: Kanta Tanaka, et al.
Published: (2021-08-01) -
Eptifibatide use in ischemic stroke patients undergoing endovascular thrombectomy: A matched cohort analysis
by: Ameena Rana, et al.
Published: (2022-09-01) -
Endovascular thrombectomy is cost-saving in patients with acute ischemic stroke with large infarct
by: Julian Schwarting, et al.
Published: (2024-04-01)